The study, “Exclusive Human Milk Diets and the Reduction of Necrotizing Enterocolitis,” compared NEC incidence in VLBW infants before and after a neonatal intensive care unit (NICU) switched from a ...

(WISH) — Almost 400,000 babies are born prematurely every year in the United States. The smaller they are, the more medical problems they can have, including one very dangerous complication that kills ...

Providing human breast milk to preterm infants is a strategy for preventing complications including necrotizing enterocolitis. Because a mother's own milk (considered the gold standard) is not always ...

Necrotizing enterocolitis (NEC) remains one of the most severe gastrointestinal emergencies affecting preterm infants. It is characterised by inflammation and necrosis of the intestinal wall, with ...

May 11, 2007 — Probiotic supplements might reduce the risk of necrotizing enterocolitis in preterm neonates, according to the results of a study reported in the May 12 issue of The Lancet. "Results of ...

Necrotizing enterocolitis (NEC) is a devastating intestinal inflammatory disease that can affect premature or otherwise medically fragile infants during their first weeks and months of life. Upon ...

Maybe probiotics would have saved my son’s life. I’ll never know because when I asked Micah’s care team to consider probiotics to counter the deluge of antibiotics, I was dismissed as senseless. My ...

Necrotizing enterocolitis (NEC) is a debilitating and deadly condition that affects infants who were born preterm. In NEC cases, intestinal tissues become inflamed, and in severe cases there is ...

DUARTE, Calif., Nov. 12, 2025 /PRNewswire/ -- A landmark systematic review and meta-analysis published in the journal Nutrients has found that an Exclusive Human Milk Diet (EHMD) with Prolacta ...

Researchers from the Quadram Institute and University of East Anglia have identified what makes some strains of gut bacteria life-threatening in pre-term babies. The findings will help identify and ...

DANVILLE, Calif.--(BUSINESS WIRE)--Nexilico, a pioneer in precision microbiome engineering, and Siolta Therapeutics, a leader in the development of live biotherapeutic products (LBPs), have entered ...